Study on Protection of Sophicarpine on Immunological Liver Injury in Mice

Yinqiu HUANG,Houqin ZHOU,Lu ZHANG,Xiaohua LU,Shizhang WEI,Yanling ZHAO
DOI: https://doi.org/10.14009/j.issn.1672-2124.2017.03.003
2017-01-01
Abstract:OBJECTIVE:To probe into the intervention effects of sophicarpine on poly Ⅰ:C/D-GalN induced immunological liver injury in mice .METHODS: 48 C57 BL/6 rice were randomly selected to be divided into four groups:blank group , model group , sophicarpine high dose group and sophicarpine low dose group , 12 cases in each . Mice were injected with different doses of sophicarpine by intragastric administration for 12 days.After the last intragastric administration, except for blank group, all rice were injected with polyⅠ:C(i.v) and D-GaIN(i.p) to develop the model of immunological liver injury .The activity of ALT, AST, CHE, ALB and TP after 12 hours and the mRNA level of TNF-α, INF-γin the liver tissue were detected by Q-PCR.The histological examination of liver tissue were conducted at the same time .RESULTS:After being treated with sophicarpine , the serums level of ALT , AST and mRNA level of TNF-α, INF-γwere obviously decreased and the serum of CHE , ALB and TP were significantly increased .According to pathological section , compared with model group , sophicarpine can reduce the degree of injury and were in a dose-dependent manner .CONCLUSIONS: Sophicarpine has an outstanding prevention treatment of polyⅠ:C/D-GalN induced immunological liver injury in mice .
What problem does this paper attempt to address?